Sphingobioma: a new and unique ingredient to restore microbiome functions

  • May. 2022
  • Supported by
  • La Roche-Posay


 

Sphingobioma is a unique bacterial strain extracted from La Roche-Posay thermal water among 400 bacterial strains. It is a non-pathogenic, flagellated and gram negative bacteria that does not possess Lipopol-ysaccharids (LPS). Its cell membrane contains glycosphingolipids (GSLs).

Its manufacturing process is marked with the "green sciences" stamp.

In vitro research showed SPHINGOBIOMA™ induces IL-10 production in human lymphocytes. IL-10 are anti-inflammatory mediators and they train skin not to over-react to allergens. This unique bacterium therefore restores the microbiome functions.

After treatment with SPHINGOBIOMA™. Green florescent staining indicating intracellular IL-10. Colour intensity is correlated with IL-10 concentration.


SPHINGOBIOMA™ has 3 properties:

1) MICROBIOME

It is respectful of the five skin commensal strains:
  • S. epidermidis,
  • S. aureus,
  • C. acnes,
  • M. furfur,
  • C. xerosis.

2) EPIDERMAL BARRIER

It improves tight junctions, it reinforces barrier function, it stimulates SASPase activity and it reduces desquamation.

3) IMMUNOMODULATION

It inhibits pro-inflammatory mediators and IgE production and it induces IL-10 production to train skin not to overt-react to allergens.